What’s Next For The Talcum Powder Litigation?
After the fourth baby powder trial resulted in a $70 million win for the plaintiff, thousands of other baby powder cancer plaintiffs eagerly await their day in court. Although it will be some time before the next baby powder lawsuit goes to trial, the litigation as a whole will be taking some big steps in the coming months.
6 Things To Know About 18-Wheeler Accidents
Although 18-wheelers and other commercial vehicles are crucial to our economy and way of life, large trucks pose some unique risks to anyone they share the roadway with. Their large size and huge weight means accidents involving 18-wheelers usually cause much more severe injuries than other types of motor vehicle accidents.
Zofran Birth Defects Litigation Update
For more than 300 families in the Zofran litigation, the process has been incredibly slow and pharmaceutical giant GlaxoSmithKline (GSK) has fought the allegations at every turn. Despite the pace, the litigation has slowly moved forward and is getting closer to a trial date.
Common Jobsite Injuries
Although the Occupational Safety and Health Administration (OSHA) set strict safety guidelines to protect American workers, thousands are still injured on the job each year. While some jobs are inherently more dangerous than others, it only takes one moment of carelessness to cause devastating injuries for workers.
J&J Loses Fourth Baby Powder Trial, Ordered To Pay $70 Million To Plaintiff
The fourth baby powder cancer lawsuit to go to trial resulted in another monumental win for plaintiffs. The jury found Johnson & Johnson (J&J) guilty of failing to warn consumers its products could cause ovarian cancer. The jury concluded the plaintiff’s long-term use of baby powder for feminine hygiene caused her ovarian cancer, and awarded her $70 million in damages. For the first time, J&J’s talc supplier, Imerys Talc America Inc., was also found guilty of failing to warn consumers and contributing to the development of cancer, and was ordered to pay $2.5 million of the $70 million award.
Dangers Faced By Teen Drivers
Learning to drive is an important milestone in life, and while teenagers might find this liberating, driving is a serious responsibility. Because of their inexperience, teenage drivers more often engage in risky driving behaviors that put themselves, their passengers, and surrounding motorists at risk of injury or death.
IVC Filters Offer No Benefit to Trauma Patients
For years, Inferior Vena Cava filters (IVC filters) were used to help mitigate the risk of blood clots in patients who cannot take traditional blood thinners. An increasing number of lawsuits claim IVC filters are defective, cause serious side effects, and have incredibly high rates of fracture. A new study published in the Journal of The American Medical Association (JAMA) found IVC filters did not provide any benefits to trauma patients.
Talcum Powder For Women: Trial Update
The fourth baby powder cancer trial began this week with plaintiff Deborah Giannecchini fighting to hold Johnson & Johnson (J&J) responsible for its negligence. Mrs. Giannecchini used J&J’s baby powder products around her groin for feminine hygiene almost daily dating as far back as 1967. In 2012, she was diagnosed with ovarian cancer. Mrs. Giannecchini stated that if the company had warned her about the ovarian cancer risk, she would have not used its products.
How Pharmaceutical Litigation Differs From Other Personal Injury Lawsuits
If a dangerous drug injured you, you probably have many questions, and seeking the counsel of a personal injury attorney can help you get answers and understand your legal options. Pharmaceutical lawsuits are very different from other personal injury lawsuits, and you will need to find a lawyer who specializes in this type of litigation to ensure you the best chance of receiving compensation.
FDA Warns Against Ovarian Cancer Screening Test
The U.S. Food and Drug Administration (FDA) issued a safety communication warning women ovarian cancer screening tests are inaccurate. The FDA is concerned women and their physicians may make important treatment decisions based on inaccurate test results.